Spots Global Cancer Trial Database for placebo control
Every month we try and update this database with for placebo control cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Effectiveness of an Adventure-based Training Programme to Reduce Fatigue for Childhood Cancer Survivors | NCT02703935 | Childhood Cance... | health talk and... Placebo Control | 9 Years - 16 Years | The University of Hong Kong | |
| GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer | NCT00480025 | Lung Cancer, No... | GSK1572932A Ant... Placebo Control | 18 Years - | GlaxoSmithKline | |
| VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy | NCT05920343 | Venous Thromboe... Urologic Cancer | Rivaroxaban 10 ... Placebo control | 18 Years - | Ottawa Hospital Research Institute | |
| Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females | NCT00586339 | Infections, Pap... | Cervarix Placebo Control | 18 Years - 25 Years | GlaxoSmithKline | |
| GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer | NCT00480025 | Lung Cancer, No... | GSK1572932A Ant... Placebo Control | 18 Years - | GlaxoSmithKline | |
| Integrated Experiential Training Program With Coaching by Nursing Students in Childhood Cancer Patients | NCT02754973 | Child Neoplasms | an integrated e... Placebo Control | 9 Years - 18 Years | The University of Hong Kong | |
| Direct Improvement of Quality of Life Using a Tailored Pathway With Quality of Life Diagnosis and Therapy: Randomised Trial in Colorectal Cancer Patients | NCT02321813 | Quality of Life Colorectal Neop... | quality of life... placebo control | 18 Years - | Tumor Center Regensburg | |
| Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors | NCT06162663 | Breast Cancer Insomnia | Suvorexant Tabl... Placebo Control | 18 Years - | Medical University of South Carolina | |
| Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older | NCT00294047 | Infections, Pap... Papillomavirus ... | Cervarix Placebo control | 26 Years - | GlaxoSmithKline | |
| Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects | NCT00779766 | Infections, Pap... | HPV GSK 580299 ... Placebo control | 18 Years - 25 Years | GlaxoSmithKline | |
| Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection | NCT04164615 | HER-2-positive ... | GB221 Placebo control | 18 Years - 70 Years | Genor Biopharma Co., Ltd. | |
| Direct Improvement of Quality of Life Using a Tailored Pathway With Quality of Life Diagnosis and Therapy: Randomised Trial in Colorectal Cancer Patients | NCT02321813 | Quality of Life Colorectal Neop... | quality of life... placebo control | 18 Years - | Tumor Center Regensburg | |
| Motivational Interviewing With Parents to Adopt and Maintain Physical Activity | NCT03983148 | Pediatric Cance... | Motivational in... Placebo control | 9 Years - 16 Years | The University of Hong Kong | |
| VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy | NCT05920343 | Venous Thromboe... Urologic Cancer | Rivaroxaban 10 ... Placebo control | 18 Years - | Ottawa Hospital Research Institute | |
| Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors | NCT06162663 | Breast Cancer Insomnia | Suvorexant Tabl... Placebo Control | 18 Years - | Medical University of South Carolina | |
| Using Information Communication Technology to Deliver Brief Motivational Interviewing | NCT03859271 | Childhood Cance... | Brief motivatio... Placebo control | 9 Years - 16 Years | The University of Hong Kong | |
| Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection | NCT04164615 | HER-2-positive ... | GB221 Placebo control | 18 Years - 70 Years | Genor Biopharma Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
